Clinical Trials Directory

Trials / Completed

CompletedNCT01368302

Attention Bias Modification Treatment (ABMT) for Patients With Post Traumatic Stress Disorder (PTSD)

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
52 (actual)
Sponsor
Tel Aviv University · Academic / Other
Sex
Male
Age
Healthy volunteers
Not accepted

Summary

Patients with Post Traumatic Stress Disorder (PTSD) will be randomly assigned to either Attention Bias Modification Treatment (ABMT) designed to normalize threat-related attention biases or a placebo control condition not designed to change attention patterns. Outcome measures will be Post Traumatic Stress Disorder (PTSD), depression, and anxiety symptoms as measured by gold standard questionnaires and symptom counts derived from structured clinical interviews. We expect to see significant Post Traumatic Stress Disorder symptom reduction in the Attention Bias Modification Treatment (ABMT) group relative to the placebo control group in which no symptomatic relief is expected.

Conditions

Interventions

TypeNameDescription
BEHAVIORALAttention Bias Modification Treatment (ABMT)Attention training using a computerized spatial attention task (dot-probe) modified to alter threat-related attention patterns.

Timeline

Start date
2011-07-01
Primary completion
2013-03-01
Completion
2013-03-01
First posted
2011-06-07
Last updated
2014-12-02

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01368302. Inclusion in this directory is not an endorsement.